332 related articles for article (PubMed ID: 34095758)
21. Thrombopoietin receptor agonists shift the balance of Fcγ receptors toward inhibitory receptor IIb on monocytes in ITP.
Liu XG; Liu S; Feng Q; Liu XN; Li GS; Sheng Z; Chen P; Liu Y; Wei Y; Dong XY; Qin P; Gao C; Ma C; Zhang L; Hou M; Peng J
Blood; 2016 Aug; 128(6):852-61. PubMed ID: 27281793
[TBL] [Abstract][Full Text] [Related]
22. Multirefractory primary immune thrombocytopenia; targeting the decreased sialic acid content.
Revilla N; Corral J; Miñano A; Mingot-Castellano ME; Campos RM; Velasco F; Gonzalez N; Galvez E; Berrueco R; Fuentes I; Gonzalez-Lopez TJ; de la Morena-Barrio ME; Gonzalez-Porras JR; Vicente V; Lozano ML
Platelets; 2019; 30(6):743-751. PubMed ID: 30296193
[TBL] [Abstract][Full Text] [Related]
23. Pathogenesis of chronic immune thrombocytopenia: increased platelet destruction and/or decreased platelet production.
Nugent D; McMillan R; Nichol JL; Slichter SJ
Br J Haematol; 2009 Sep; 146(6):585-96. PubMed ID: 19466980
[TBL] [Abstract][Full Text] [Related]
24. Pathophysiology of immune thrombocytopenia.
Li J; Sullivan JA; Ni H
Curr Opin Hematol; 2018 Sep; 25(5):373-381. PubMed ID: 30015642
[TBL] [Abstract][Full Text] [Related]
25. Romiplostim as a treatment for immune thrombocytopenia: a review.
Chalmers S; Tarantino MD
J Blood Med; 2015; 6():37-44. PubMed ID: 25632241
[TBL] [Abstract][Full Text] [Related]
26. Autoimmune thrombocytopenia: flow cytometric determination of platelet-associated CD154/CD40L and CD40 on peripheral blood T and B lymphocytes.
Meabed MH; Taha GM; Mohamed SO; El-Hadidy KS
Hematology; 2007 Aug; 12(4):301-7. PubMed ID: 17654056
[TBL] [Abstract][Full Text] [Related]
27. [Recent advances in pathophysiology and treatment of immune thrombocytopenia].
Kashiwagi H; Tomiyama Y
Rinsho Ketsueki; 2015 Feb; 56(2):177-84. PubMed ID: 25765798
[TBL] [Abstract][Full Text] [Related]
28. Antiplatelet antibody-induced thrombocytopenia does not correlate with megakaryocyte abnormalities in murine immune thrombocytopenia.
Guo L; Kapur R; Aslam R; Hunt K; Hou Y; Zufferey A; Speck ER; Rondina MT; Lazarus AH; Ni H; Semple JW
Scand J Immunol; 2018 Jul; 88(1):e12678. PubMed ID: 29855061
[TBL] [Abstract][Full Text] [Related]
29. T cells in the pathogenesis of immune thrombocytopenia.
Wei Y; Hou M
Semin Hematol; 2016 Apr; 53 Suppl 1():S13-5. PubMed ID: 27312155
[TBL] [Abstract][Full Text] [Related]
30. Downregulation of hypoxia-inducible factor-1α contributes to impaired megakaryopoiesis in immune thrombocytopenia.
Qi J; You T; Pan T; Wang Q; Zhu L; Han Y
Thromb Haemost; 2017 Oct; 117(10):1875-1886. PubMed ID: 28771276
[TBL] [Abstract][Full Text] [Related]
31. The many facets of immune-mediated thrombocytopenia: Principles of immunobiology and immunotherapy.
Moulinet T; Moussu A; Pierson L; Pagliuca S
Blood Rev; 2024 Jan; 63():101141. PubMed ID: 37980261
[TBL] [Abstract][Full Text] [Related]
32. Mouse immune thrombocytopenia is associated with Th1 bias and expression of activating Fcγ receptors.
Nishimoto T; Okazaki Y; Numajiri M; Kuwana M
Int J Hematol; 2017 May; 105(5):598-605. PubMed ID: 28028748
[TBL] [Abstract][Full Text] [Related]
33. Pathogenesis and Therapeutic Mechanisms in Immune Thrombocytopenia (ITP).
Zufferey A; Kapur R; Semple JW
J Clin Med; 2017 Feb; 6(2):. PubMed ID: 28208757
[TBL] [Abstract][Full Text] [Related]
34. Advances in the pathophysiology of primary immune thrombocytopenia.
Perera M; Garrido T
Hematology; 2017 Jan; 22(1):41-53. PubMed ID: 27670221
[TBL] [Abstract][Full Text] [Related]
35. Romiplostim: a second-generation thrombopoietin agonist.
Cohn CS; Bussel JB
Drugs Today (Barc); 2009 Mar; 45(3):175-88. PubMed ID: 19436840
[TBL] [Abstract][Full Text] [Related]
36. Fc-independent phagocytosis: implications for IVIG and other therapies in immune-mediated thrombocytopenia.
Li J; van der Wal DE; Zhu L; Vadasz B; Simpson EK; Li C; Webster ML; Zhu G; Lang S; Chen P; Zeng Q; Ni H
Cardiovasc Hematol Disord Drug Targets; 2013 Mar; 13(1):50-8. PubMed ID: 23082940
[TBL] [Abstract][Full Text] [Related]
37. Pathogenesis of immune thrombocytopenia in common variable immunodeficiency.
Tinazzi E; Osti N; Beri R; Argentino G; Veneri D; Dima F; Bason C; Jadav G; Dolcino M; Puccetti A; Lunardi C
Autoimmun Rev; 2020 Sep; 19(9):102616. PubMed ID: 32682985
[TBL] [Abstract][Full Text] [Related]
38. Icaritin Provokes Serum Thrombopoietin and Downregulates Thrombopoietin/MPL of the Bone Marrow in a Mouse Model of Immune Thrombocytopenia.
Zhang K; Dai Z; Liu R; Tian F; Liu X; Sun Y; Zhao X; Pu X
Mediators Inflamm; 2018; 2018():7235639. PubMed ID: 30224899
[TBL] [Abstract][Full Text] [Related]
39. Autoantibody-mediated complement activation on platelets is a common finding in patients with immune thrombocytopenic purpura (ITP).
Najaoui A; Bakchoul T; Stoy J; Bein G; Rummel MJ; Santoso S; Sachs UJ
Eur J Haematol; 2012 Feb; 88(2):167-74. PubMed ID: 21985182
[TBL] [Abstract][Full Text] [Related]
40. Potential Diagnostic Approaches for Prediction of Therapeutic Responses in Immune Thrombocytopenia.
Jolink AC; Nelson VS; Schipperus MR; Amini SN; Vidarsson G; van der Schoot CE; Porcelijn L; de Haas M; Kapur R
J Clin Med; 2021 Jul; 10(15):. PubMed ID: 34362187
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
